Effect of expectancy and personality on cortical excitability in Parkinson's disease

Movement Disorders

Volumn 28, Issue 9, 2013, Pages 1257-1262

  Lou, Jau Shin ^a   Dimitrova, Diana M ^a   Hammerschlag, Richard ^b   Nutt, John ^a   Hunt, Elizabeth A ^a   Eaton, Ryan W ^a   Johnson, Sarah C ^a   Davis, Melanie D ^a   Arnold, Grace C ^a   Andrea, Sarah B ^a   Oken, and Barry S ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON COLLEGE OF ORIENTAL MEDICINE   (United States)

Author keywords

Cortical excitability; Expectancy; Levodopa; Parkinson's disease; Transcranial magnetic stimulation (TMS)

Indexed keywords

LEVODOPA; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; EVOKED MUSCLE RESPONSE; EXCITABILITY; FATIGUE; FEMALE; HUMAN; LIFE EXPECTANCY; MALE; PARKINSON DISEASE; PERSONALITY; PLACEBO EFFECT; PRIORITY JOURNAL; TRANSCRANIAL MAGNETIC STIMULATION;

CORTICAL EXCITABILITY; EXPECTANCY; LEVODOPA; PARKINSON'S DISEASE; TRANSCRANIAL MAGNETIC STIMULATION (TMS);

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIPARKINSON AGENTS; CEREBRAL CORTEX; DOUBLE-BLIND METHOD; EVOKED POTENTIALS, MOTOR; FATIGUE; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MOTIVATION; MOTOR ACTIVITY; PARKINSON DISEASE; PERSONALITY; PERSONALITY INVENTORY; QUESTIONNAIRES;

EID: 84883557051     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25471     Document Type: Article

References (31)

1. Goetz CG, Wuu J, McDermott MP, et al. Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions. Mov Disord. 2008;23:690-699.
2. Goetz CG, Leurgans S, Raman R, Parkinson Study Group. Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease. Mov Disord. 2002;17:283-288.
3. Oken B. Placebo effects: clinical aspects and neurobiology. Brain. 2008;131:2812-2823.
4. de la Fuente-Fernández R, Ruth TJ, Sossi V, Schulzer M, Calne DB, Stoessl AJ. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science. 2001;293:1164-1166.
5. Strafella AP, Ko JH, Monchi O. Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: the contribution of expectation. Neuroimage. 2006;31:1666-1672.
6. de la Fuente-Fernández R. Dopamine release in human ventral striatum and expectation of reward. Behav Brain Res. 2002;136:359-363.
7. Mercado R, Constantoyannis C, Mandat T, et al. Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation. Mov Disord. 2006;21:1457-1461.
8. Beedie C, Foad A, Coleman D. Identification of placebo responsive participants in 40km laboratory cycling performance. J Sports Sci Med. 2008;7:166-175.
9. Karlsen K, Larsen JP, Tandberg E, Jørgensen K. Fatigue in patients with Parkinson's disease. Mov Disord. 1999;14:237-241.
10. Lou JS. Physical and mental fatigue in Parkinson's disease: epidemiology, pathophysiology, and treatments. Drug Aging. 2009;26:195-208.
11. Lou JS, Benice T, Kearns G, Sexton G, Nutt J. Levodopa normalizes exercise related cortico-motoneuron excitability abnormalities in Parkinson's disease. Clin Neurophysiol. 2003;114:930-937.
12. Lou JS, Kearns G, Benice T, Oken B, Sexton G, Nutt J. Levodopa improves physical fatigue in Parkinson's disease: a double-blind, placebo-controlled, crossover study. Mov Disord. 2003;18:1108-1114.
13. American Psychological Association. Ethical principles of psychologists and code of conduct. Am Psychol. 2002;57:1060-1073.
14. National Bioethics Advisory Commission. Ethical and policy issues in research involving human participants. Report and Recommendations of the National Bioethics Advisory Commission 2001:135.
15. Costa PT, McCrae RR, eds. Revised NEO Personality Inventory and NEO Five-Factor Inventory: Professional Manual. Lutz, FL: Psychological Assessment Resources, Inc.; 1992:101.
16. Schwarzer R, Jerusalem M. Measures in health psychology: a user's portfolio. In: Weinman J, Wright S, Johnston M, eds. Windsor, England: NFER-NELSON; 1995:35-37.
17. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385-396.
18. McRae C, Cherin E, Yamazaki T, et al. Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial. Arch Gen Psychiatry. 2004;61:412-420.
19. Pollo A, Benedetti F. The placebo response: neurobiological and clinical issues of neurological relevance. Prog Brain Res. 2009;175:283-294.
20. Tobler PN, Fiorillo CD, Schultz W. Adaptive coding of reward value by dopamine neurons. Science. 2005;307:1642-1645.
21. Fiorillo CD, Tobler PN, Schultz W. Discrete coding of reward probability and uncertainty by dopamine neurons. Science. 2003;299:1898-1902.
22. Lidstone SC, Schulzer M, Dinelle K, et al. Effects of expectation on placebo-induced dopamine release in Parkinson disease. Arch Gen Psychiatry. 2010;67:857-865.
23. O'Doherty J, Dayan P, Schultz J, Deichmann R, Friston K, Dolan RJ. Dissociable roles of ventral and dorsal striatum in instrumental conditioning. Science. 2004;304:452-454.
24. Lou JS, Eaton R, Blaine K, Coakley B, Sexton G, Nutt J. Motor-evoked potential as a physiological marker for the placebo effect in PD. Ann Neurol. 2005;58:S53.
25. Wassermann EM. Variation in the response to transcranial magnetic brain stimulation in the general population. Clin Neurophysiol. 2002:113:1165-1171.
26. Smith MJ. Adams LF. Schmidt PJ. Rubinow DR. Wassermann EM. Abnormal luteal phase excitability of the motor cortex in women with premenstrual syndrome. Biol Psychiatry. 2003;54:757-762.
27. Leon-Sarmiento FE. Bara-Jimenez W. Wassermann EM. Visual deprivation effects on human motor cortex excitability. Neurosci Lett. 2005;389:17-20.
28. Geers AL, Kosbab K, Helfer SG, Weiland PE, Wellman JA. Further evidence for individual differences in placebo responding: an interactionist perspective. J Psychosom Res. 2007;62:563--570.
29. Crow R, Gage H, Hampson S, Hart J, Kimber A, Thomas H. The role of expectancies in the placebo effect and their use in the delivery of health care: a systematic review. Health Technol Assess. 1999;3:1-96.
30. Smeets R J, Maher CG, Nicholas MK, Refshauge KM, Herbert RD. Do psychological characteristics predict response to exercise and advice for subacute low back pain? Arthritis Rheum. 2009;61:1202-1209.
31. Litt MD, Nye C, Shafer D. Coping with oral surgery by self-efficacy enhancement and perceptions of control. J Dent Res. 1993;72:1237-1243.